{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 3.2090192, "regularMarketPrice": 11.9, "exchange": "NMS", "shortName": "Cogent Biosciences, Inc.", "longName": "Cogent Biosciences, Inc.", "messageBoardId": "finmb_675599465", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": 2.717, "fiftyDayAverage": 11.1514, "fiftyDayAverageChange": 0.7486, "fiftyDayAverageChangePercent": 0.06713059, "twoHundredDayAverage": 12.865425, "twoHundredDayAverageChange": -0.9654255, "twoHundredDayAverageChangePercent": -0.07504031, "marketCap": 853785728, "forwardPE": -5.613208, "priceToBook": 4.3798304, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Unum Therapeutics Inc.", "nameChangeDate": "2023-05-15", "averageAnalystRating": "1.4 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "earningsTimestamp": 1683633601, "earningsTimestampStart": 1691406000, "earningsTimestampEnd": 1691751600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.36, "epsForward": -2.12, "epsCurrentYear": -2.24, "priceEpsCurrentYear": -5.3125, "sharesOutstanding": 70946800, "firstTradeDateMilliseconds": 1522330200000, "priceHint": 2, "regularMarketChange": 0.3699999, "regularMarketTime": 1684180804, "regularMarketDayHigh": 12.0, "regularMarketDayRange": "11.52 - 12.0", "regularMarketDayLow": 11.52, "regularMarketVolume": 732505, "regularMarketPreviousClose": 11.53, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 10, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 11.52, "averageDailyVolume3Month": 641446, "averageDailyVolume10Day": 689930, "fiftyTwoWeekLowChange": 7.8999996, "fiftyTwoWeekLowChangePercent": 1.9749999, "fiftyTwoWeekRange": "4.0 - 18.07", "fiftyTwoWeekHighChange": -6.17, "fiftyTwoWeekHighChangePercent": -0.34144992, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 18.07, "dividendDate": 1604880000, "marketState": "PRE", "displayName": "Cogent Biosciences", "symbol": "COGT"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "275 Wyman Street", "address2": "3rd Floor", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "617 945 5576", "website": "https://www.cogentbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target exon 17 mutations found within the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 138, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew R. Robbins M.B.A.", "age": 46, "title": "Pres, CEO & Director", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 981403, "fmt": "981.4k", "longFmt": "981,403"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1230115, "fmt": "1.23M", "longFmt": "1,230,115"}}, {"maxAge": 1, "name": "Dr. John Edward Robinson Ph.D.", "age": 48, "title": "Chief Scientific Officer", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": {"raw": 633726, "fmt": "633.73k", "longFmt": "633,726"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 835001, "fmt": "835k", "longFmt": "835,001"}}, {"maxAge": 1, "name": "Dr. Jessica  Sachs M.D.", "age": 47, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 672502, "fmt": "672.5k", "longFmt": "672,502"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1742244, "fmt": "1.74M", "longFmt": "1,742,244"}}, {"maxAge": 1, "name": "Mr. John L. Green C.A., CPA", "age": 42, "title": "CFO & Principal Accounting Officer", "yearBorn": 1980, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brad  Barnett", "title": "Chief Technology Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Evan D. Kearns J.D.", "age": 42, "title": "Chief Legal Officer & Corp. Sec.", "yearBorn": 1980, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Erin  Schellhammer", "title": "Chief People Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sara  Saltzman", "title": "Sr. VP of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Dana R. Martin Pharm.D.", "title": "Sr. VP of Medical Affairs & Chief Patient Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Brad  Fell", "title": "VP & Head of Medicinal Chemistry", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}